{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T06:32:24Z","timestamp":1768458744938,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.ygyno.2013.08.005","type":"journal-article","created":{"date-parts":[[2013,8,9]],"date-time":"2013-08-09T17:56:07Z","timestamp":1376070967000},"page":"341-346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":95,"title":["Introduction of staging laparoscopy in the management of advanced epithelial ovarian, tubal and peritoneal cancer: Impact on prognosis in a single institution experience"],"prefix":"10.1016","volume":"131","clinical-trial-number":[{"clinical-trial-number":"nct00712218","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01461850","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"A.","family":"Fagotti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Vizzielli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Fanfani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Costantini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Ferrandina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Gallotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Gueli Alletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Tortorella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Scambia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2013.08.005_bb0005","series-title":"Cancer facts & figures","year":"2010"},{"key":"10.1016\/j.ygyno.2013.08.005_bb0010","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0002-9378(94)70090-7","article-title":"The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma","volume":"170","author":"Hoskins","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.08.005_bb0015","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ygyno.2006.03.051","article-title":"What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?","volume":"103","author":"Chi","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.08.005_bb0020","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2013.08.005_bb0025","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1200\/JCO.2006.10.2517","article-title":"Gynecologic oncology group. Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study","volume":"25","author":"Winter","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2013.08.005_bb0030","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"European Organization for Research and Treatment of Cancer \u2014 Gynecological Cancer Group; NCIC Clinical Trials Group. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ygyno.2013.08.005_bb0035","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ygyno.2004.11.031","article-title":"Role of laparoscopy to assess the chance of optimal cytoreductive surgery in advanced ovarian cancer: a pilot study","volume":"96","author":"Fagotti","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.ygyno.2013.08.005_bb0040","doi-asserted-by":"crossref","first-page":"642.e1","DOI":"10.1016\/j.ajog.2008.06.052","article-title":"Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma","volume":"199","author":"Fagotti","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.ygyno.2013.08.005_bb0045","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/j.1600-0412.2011.01227.x","article-title":"Learning curve and pitfalls of a laparoscopic score to describe peritoneal carcinosis in advanced ovarian cancer","volume":"90","author":"Fagotti","year":"2011","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"10.1016\/j.ygyno.2013.08.005_bb0050","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ygyno.2009.09.015","article-title":"Should laparoscopy be included in the work-up of advanced ovarian cancer patients attempting interval debulking surgery?","volume":"116","author":"Fagotti","year":"2010","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2013.08.005_bb0055","doi-asserted-by":"crossref","first-page":"178.e1","DOI":"10.1016\/j.ajog.2009.10.856","article-title":"Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in advanced ovarian cancer","volume":"202","author":"Ch\u00e9reau","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.08.005_bb0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2407-12-31","article-title":"Laparoscopy to predict the result of primary cytoreductive surgery in advanced ovarian cancer patients (LapOvCa-trial): a multicentre randomized controlled study","volume":"12","author":"Rutten","year":"2012","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2013.08.005_bb0065","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ygyno.2010.09.010","article-title":"Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment","volume":"120","author":"Aletti","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.08.005_bb0070","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ygyno.2004.01.029","article-title":"Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach","volume":"94","author":"Chi","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.08.005_bb0075","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2013.08.005_bb0080","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1200\/JCO.2001.19.20.4054","article-title":"Use of CA-125 to define progression of ovarian cancer in patients with persistently elevated levels","volume":"19","author":"Rustin","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2013.08.005_bb0085","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.ygyno.2013.08.005_bb0090","first-page":"163","article-title":"Evaluation of survival data and two new rank order statistics arising in its consideration","volume":"50","author":"Mantel","year":"1996","journal-title":"Cancer Chemother Rep"},{"issue":"3","key":"10.1016\/j.ygyno.2013.08.005_bb0095","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.ygyno.2013.08.005_bb0100","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ygyno.2012.09.020","article-title":"Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: a case\u2013control study on survival in patients with two year follow-up","volume":"127","author":"Fagotti","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2013.08.005_bb0105","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ygyno.2008.08.024","article-title":"The rate of port-site metastases after 2251 laparoscopic procedures in women with underlying malignant disease","volume":"111","author":"Zivanovic","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2013.08.005_bb0110","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ygyno.2010.07.032","article-title":"Role of maximal primary cytoreductive surgery in patients with advanced epithelial ovarian and tubal cancer: surgical and oncological outcomes. Single institution experience","volume":"119","author":"Peiretti","year":"2010","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2013.08.005_bb0115","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ygyno.2011.08.014","article-title":"An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT)","volume":"124","author":"Chi","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2013.08.005_bb0120","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1200\/JCO.2007.13.1953","article-title":"McGuire WP; Gynecologic Oncology Group. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study","volume":"26","author":"Winter","year":"2008","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.ygyno.2013.08.005_bb0125","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/sj.bjc.6605292","article-title":"Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial","volume":"101","author":"Ferrandina","year":"2009","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2013.08.005_bb0130","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3109\/0284186X.2010.500296","article-title":"Standardized FDG uptake as a prognostic variable and as a predictor of incomplete cytoreduction in primary advanced ovarian cancer","volume":"50","author":"Risum","year":"2011","journal-title":"Acta Oncol"},{"issue":"9","key":"10.1016\/j.ygyno.2013.08.005_bb0135","first-page":"2636","article-title":"Sainz De La Cuesta R","volume":"23","author":"Espada","year":"2013","journal-title":"Diffusion-weighted magnetic resonance imaging evaluation of intra-abdominal sites of implants to predict likelihood of suboptimal cytoreductive surgery in patients with ovarian carcinoma. Eur Radiol Sep"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813010834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813010834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T22:52:07Z","timestamp":1539471127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825813010834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0090825813010834"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.08.005","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Introduction of staging laparoscopy in the management of advanced epithelial ovarian, tubal and peritoneal cancer: Impact on prognosis in a single institution experience","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}